News Novartis AG Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 16:31:54 17/06/2024 BST			5-day change	1st Jan Change
93.77 ^CHF	-1.46%		-0.61%	+10.88%

06-14	EU regulator mandates label updates on CAR-T cancer therapies	RE
06-14	PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	MT

EU regulator mandates label updates on CAR-T cancer therapies	06-14	RE
PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	06-14	MT
Nkarta, Inc. Appoints George Vratsanos as Board of Directors	06-13	CI
NOVARTIS AG : JP Morgan reiterates its Neutral rating	06-11	ZD
Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy	06-07	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	06-07	MT
AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation	06-06	MT
Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists	06-06	RE
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	06-06	DJ
Novartis and others face Italy antitrust probe over eye drug	06-06	RE
Three newcomers to the MDax - Rational, TUI and Traton move up	06-06	RE
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout	06-05	DJ
The odds of rates getting cut in 2024 may be better than you think	06-05
NOVARTIS AG : Deutsche Bank maintains a Buy rating	06-05	ZD
Bank Vontobel Lifts Price Target on Novartis, Maintains Buy Recommendation	06-04	MT
NOVARTIS AG : JP Morgan remains Neutral	06-03	ZD
NOVARTIS AG : Buy rating from Goldman Sachs	06-03	ZD
NOVARTIS : UBS reiterates buy recommendation after ASCO	06-03	CF
SMA Solar and Morphosys are about to leave the MDax	06-03	RE
NOVARTIS AG : UBS gives a Buy rating	06-03	ZD